Evotec AG O.N. (EVTG)

9.760 -0.510 (-4.97%)
Closed EUR Disclaimer

Evotec AG O.N. Company Profile

Equity Type
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women’s health. It has collaboration agreements with SK bioscience, JingXin, Carrick Therapeutics, Sernova, Topas Therapeutics, Exscientia, CONBA Group, Centrexion, Sanofi/NIH, Kazia Therapeutics, Bristol Myers Squibb, Topas Therapeutics, Immunitas, Exscientia, and Bayer, as well as a strategic partnership with Dewpoint Therapeutics to advance its portfolio targeting biomolecular condensates as a novel domain for therapeutic intervention towards the clinic. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.
Contact Information
Hamburg,22419 Germany
49 40 560 81 0
49 40 560 81 222
Top Executives
Iris Low-Friedrich 62 2014 Independent Chairperson of the Supervisory Board
Camilla Macapili Languille 0 2022 Member of the Supervisory Board
Elaine Sullivan 61 2015 Independent Member of Supervisory Board
Roland Sackers 55 2019 Independent Vice Chairperson of the Supervisory Board
Constanze Ulmer-Eilfort 61 2021 Independent Member of Supervisory Board
Mario Polywka 61 2004 CEO & Chairman of the Management Board & Member of the Supervisory Board
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.